Category: Foundation Fournier-Majoie

Foundation Fournier-Majoie

A promising new project in targeted cancer therapies

The Foundation Fournier-Majoie is contributing € 500,000 to the Mablink Bioscience project to build a new generation of ADCs, a class of drugs targeted against cancer (FR)

Read more